212 related articles for article (PubMed ID: 24754415)
1. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
[TBL] [Abstract][Full Text] [Related]
2. Infectious Complications and Immune/Inflammatory Response in Cardiogenic Shock Patients: A Prospective Observational Study.
Parenica J; Jarkovsky J; Malaska J; Mebazaa A; Gottwaldova J; Helanova K; Litzman J; Dastych M; Tomandl J; Spinar J; Dostalova L; Lokaj P; Tomandlova M; Pavkova MG; Sevcik P; Legrand M;
Shock; 2017 Feb; 47(2):165-174. PubMed ID: 27749762
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality.
Parenica J; Malaska J; Jarkovsky J; Lipkova J; Dastych M; Helanova K; Litzman J; Tomandl J; Littnerova S; Sevcikova J; Gal R; Sevcik P; Spinar J; Goldbergova MP
Exp Clin Cardiol; 2012; 17(4):205-9. PubMed ID: 23592937
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study highlights shared aspects of the transcriptomic response to cardiogenic and septic shock.
Braga D; Barcella M; Herpain A; Aletti F; Kistler EB; Bollen Pinto B; Bendjelid K; Barlassina C
Crit Care; 2019 Dec; 23(1):414. PubMed ID: 31856860
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data.
Picariello C; Lazzeri C; Valente S; Chiostri M; Attanà P; Gensini GF
Acute Card Care; 2010 Sep; 12(3):96-101. PubMed ID: 20698733
[TBL] [Abstract][Full Text] [Related]
6. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6.
Geppert A; Steiner A; Zorn G; Delle-Karth G; Koreny M; Haumer M; Siostrzonek P; Huber K; Heinz G
Crit Care Med; 2002 Sep; 30(9):1987-94. PubMed ID: 12352031
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
[TBL] [Abstract][Full Text] [Related]
8. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.
Sionis A; Suades R; Sans-Roselló J; Sánchez-Martínez M; Crespo J; Padró T; Cubedo J; Ferrero-Gregori A; Vila-Perales M; Duran-Cambra A; Badimon L
Int J Cardiol; 2018 May; 258():249-256. PubMed ID: 29544939
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
de Werra I; Jaccard C; Corradin SB; Chioléro R; Yersin B; Gallati H; Assicot M; Bohuon C; Baumgartner JD; Glauser MP; Heumann D
Crit Care Med; 1997 Apr; 25(4):607-13. PubMed ID: 9142024
[TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation into adrenal responsiveness and outcomes in patients with cardiogenic shock after acute myocardial infarction.
Tol MM; Shekar K; Barnett AG; McGree J; McWhinney BC; Ziegenfuss M; Ungerer JP; Fraser JF
J Crit Care; 2014 Jun; 29(3):470.e1-6. PubMed ID: 24656116
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.
Debrunner M; Schuiki E; Minder E; Straumann E; Naegeli B; Mury R; Bertel O; Frielingsdorf J
Clin Res Cardiol; 2008 May; 97(5):298-305. PubMed ID: 18491171
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
Yang JH; Song PS; Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim YJ; Gwon HC
Crit Care; 2013 Oct; 17(5):R218. PubMed ID: 24090250
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.
Obling L; Frydland M; Hansen R; Møller-Helgestad OK; Lindholm MG; Holmvang L; Ravn HB; Wiberg S; Thomsen JH; Jensen LO; Kjærgaard J; Møller JE; Hassager C
Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):7-15. PubMed ID: 28452562
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock.
Pudil R; Krejsek J; Pidrman V; Gregor J; Tichý M; Bures J
Acta Medica (Hradec Kralove); 2001; 44(4):149-51. PubMed ID: 11836852
[TBL] [Abstract][Full Text] [Related]
16. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
Andrié RP; Becher UM; Frommold R; Tiyerili V; Schrickel JW; Nickenig G; Schwab JO
Crit Care; 2012 Aug; 16(4):R152. PubMed ID: 22889197
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.
Link A; Pöss J; Rbah R; Barth C; Feth L; Selejan S; Böhm M
Eur Heart J; 2013 Jun; 34(22):1651-62. PubMed ID: 23349297
[TBL] [Abstract][Full Text] [Related]
19. Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission.
Akkus MN; Polat G; Yurtdas M; Akcay B; Ercetin N; Cicek D; Doven O; Sucu N
Int Heart J; 2009 Jan; 50(1):33-45. PubMed ID: 19246845
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.
Prondzinsky R; Unverzagt S; Lemm H; Wegener NA; Schlitt A; Heinroth KM; Dietz S; Buerke U; Kellner P; Loppnow H; Fiedler MG; Thiery J; Werdan K; Buerke M
Clin Res Cardiol; 2012 May; 101(5):375-84. PubMed ID: 22212516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
